Quick Takeaways
- Akram Mahesh filed SCHEDULE 13G/A for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX).
- Disclosed ownership: 6.6%.
- Date of event: 31 Mar 2025.
Akram Mahesh - 31 Mar 2025 SCHEDULE 13G/A Report for Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX)
- Filing Manager
- Akram Mahesh
- Reporting Manager
- Akram Mahesh
- Symbol
- AMRX
- Shares outstanding
- 313,395,716 shares
- Disclosed Ownership
- 20,558,759 shares
- Ownership
- 6.6%
- Form type
- SCHEDULE 13G/A
- Filing time
- 14 May 2025, 17:03:57 UTC
- Date of event
- 31 Mar 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Akram Mahesh disclosed 6.6% ownership in Amneal Pharmaceuticals, Inc. Class A Common Stock, par value $0.01 (AMRX) on 31 Mar 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 14 May 2025, 17:03.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Akram Mahesh | 6.6% | 20,558,759 | 20,558,759 | 0 | Akram Mahesh | Akram Mahesh |